Intimation regarding proposed re-appointment of director pursuant to retirement by rotation, grant of stock options, application to NSE.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fermenta Biotech Ltd announced five key board decisions. First, the re-appointment of Ms. Rajeshwari Datla (76 years old) as Non-Executive Director, who is mother of Executive Director Anupama Datla Desai and Executive-Vice Chairman Krishna Datla. The board also approved her continuation beyond the SEBI-mandated 75-year age limit, requiring member approval. Second, the Compensation Committee granted 395,400 stock options to eligible employees under FBL ESOP 2025 at an exercise price of Rs. 83.67 per option, with a minimum 1-year vesting period. Third, the board approved filing an application with NSE for direct listing of the company's equity shares. Fourth, in-principle approval was granted to wholly-owned subsidiary Fermenta Environment Solutions Private Limited (FESPL) for a private placement of equity shares, which would cause FESPL to cease being a wholly-owned subsidiary. Fifth, FESPL was approved to implement its own Employee Stock Option Plan 2026.
The re-appointment and age waiver approval is routine but signals strong promoter family control continuing on the board. The NSE listing application is positive for liquidity and investor reach. The ESOP grant aligns employee interests with shareholders. The FESPL private placement may reduce the company's stake in its environmental subsidiary.